Literature DB >> 23013406

Genome-wide linkage scan for psoriasis susceptibility loci in multiplex Tunisian families.

M Ammar1, C Bouchlaka-Souissi, C A Helms, I Zaraa, C T Jordan, H Anbunathan, R Bouhaha, S Kouidhi, N Doss, R Dhaoui, A Ben Osman, A Ben Ammar El Gaied, R Marrakchi, M Mokni, A M Bowcock.   

Abstract

BACKGROUND: Psoriasis is a relapsing chronic inflammatory skin disease affecting all population groups, with a peak prevalence of 3% in northern European and Scandinavian caucasians. Epidemiological studies have implicated a genetic component to psoriasis. In the past 12 years multiple genome-wide linkage analyses have identified putative susceptibility loci on several chromosomes, with a major locus in the major histocompatibility complex region.
OBJECTIVES: To investigate the genetic basis of familial psoriasis in the Tunisian population using a genome-wide linkage scan in seven ultiplex psoriatic families from Tunisia.
METHODS: Following single nucleotide polymorphism (SNP) genotyping on the Affymetrix 10K SNP array, we performed nonparametric linkage (NPL) multipoint analyses to identify genotypes and obtain evidence for linkage with psoriasis across the genome.
RESULTS: No chromosomal region gave consistent evidence for linkage, providing evidence for genetic heterogeneity in Tunisian psoriasis families. Significant evidence for linkage of psoriasis to chromosome 2p12 was seen in one family. We also identified several regions of tentative psoriasis linkage on chromosomes 2q, 4q, 6p, 11q, 12q, 9q and 13q. One family exhibiting suggestive evidence for linkage to 17q25 (PSORS2) was identified and all affected members harboured a p.Gly117Ser mutation in CARD14 (caspase recruitment domain family, member 14), recently reported to lead to psoriasis in a large family from the U.S.A.
CONCLUSIONS: Our results support the genetic heterogeneity of psoriasis in the Tunisian population, provide confirmatory evidence for a novel psoriasis locus at chromosome 2p12 and reveal a psoriasis family with a mutation at PSORS2.
© 2012 The Authors. BJD © 2012 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23013406     DOI: 10.1111/bjd.12050

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  7 in total

1.  CARD14 alterations in Tunisian patients with psoriasis and further characterization in European cohorts.

Authors:  M Ammar; C T Jordan; L Cao; E Lim; C Bouchlaka Souissi; A Jrad; I Omrane; S Kouidhi; I Zaraa; H Anbunathan; M Mokni; N Doss; E Guttman-Yassky; A B El Gaaied; A Menter; A M Bowcock
Journal:  Br J Dermatol       Date:  2015-11-17       Impact factor: 9.302

2.  Activating CARD14 Mutations Are Associated with Generalized Pustular Psoriasis but Rarely Account for Familial Recurrence in Psoriasis Vulgaris.

Authors:  Dorottya M Berki; Lu Liu; Siew-Eng Choon; A David Burden; Christopher E M Griffiths; Alexander A Navarini; Eugene S Tan; Alan D Irvine; Annamari Ranki; Takeshi Ogo; Gabriela Petrof; Satveer K Mahil; Michael Duckworth; Michael H Allen; Pasquale Vito; Richard C Trembath; John McGrath; Catherine H Smith; Francesca Capon; Jonathan N Barker
Journal:  J Invest Dermatol       Date:  2015-07-23       Impact factor: 8.551

3.  Variants of CARD14 gene and psoriasis vulgaris in southern Chinese cohort.

Authors:  Kunju Zhu; Ge Shi; Huan Liu; Chengyao Zhu; Yiming Fan
Journal:  An Bras Dermatol       Date:  2016 Jan-Feb       Impact factor: 1.896

4.  Efficacy of Methotrexate in patients with plaque type psoriasis.

Authors:  Sabiqa Haider; Zarnaz Wahid; Farzana Riaz
Journal:  Pak J Med Sci       Date:  2014-09       Impact factor: 1.088

5.  Increased Risk of Psoriasis due to combined effect of HLA-Cw6 and LCE3 risk alleles in Indian population.

Authors:  Aditi Chandra; Anirudhya Lahiri; Swapan Senapati; Baidehi Basu; Saurabh Ghosh; Indranil Mukhopadhyay; Akhilesh Behra; Somenath Sarkar; Gobinda Chatterjee; Raghunath Chatterjee
Journal:  Sci Rep       Date:  2016-04-06       Impact factor: 4.379

6.  The E3 Ubiquitin Ligase RNF7 Negatively Regulates CARD14/CARMA2sh Signaling.

Authors:  Gianluca Telesio; Ivan Scudiero; Maddalena Pizzulo; Pellegrino Mazzone; Tiziana Zotti; Serena Voccola; Immacolata Polvere; Pasquale Vito; Romania Stilo
Journal:  Int J Mol Sci       Date:  2017-12-01       Impact factor: 5.923

Review 7.  Clinical and Genetic Heterogeneity of CARD14 Mutations in Psoriatic Skin Disease.

Authors:  Laura Israel; Mark Mellett
Journal:  Front Immunol       Date:  2018-10-16       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.